Literature DB >> 27081018

Functional Aortic Root Parameters and Expression of Aortopathy in Bicuspid Versus Tricuspid Aortic Valve Stenosis.

Evaldas Girdauskas1, Mina Rouman2, Kushtrim Disha2, Beatrix Fey3, Georg Dubslaff3, Bernhard Theis4, Iver Petersen4, Matthias Gutberlet5, Michael A Borger6, Thomas Kuntze2.   

Abstract

BACKGROUND: The correlation between bicuspid aortic valve (BAV) disease and aortopathy is not fully defined.
OBJECTIVES: This study aimed to prospectively analyze the correlation between functional parameters of the aortic root and expression of aortopathy in patients undergoing surgery for BAV versus tricuspid aortic valve (TAV) stenosis.
METHODS: From January 1, 2012 through December 31, 2014, 190 consecutive patients (63 ± 8 years, 67% male) underwent aortic valve replacement ± proximal aortic surgery for BAV stenosis (n = 137, BAV group) and TAV stenosis (n = 53, TAV group). All patients underwent pre-operative cardiac magnetic resonance imaging to evaluate morphological/functional parameters of the aortic root. Aortic tissue was sampled during surgery on the basis of the location of eccentric blood flow contact with the aortic wall, as determined by cardiac magnetic resonance (i.e., jet sample and control sample). Aortic wall lesions were graded using a histological sum score (0 to 21).
RESULTS: The largest cross-sectional aortic diameters were at the mid-ascending level in both groups and were larger in BAV patients (40.2 ± 7.2 mm vs. 36.6 ± 3.3 mm, respectively, p < 0.001). The histological sum score was 2.9 ± 1.4 in the BAV group versus 3.4 ± 2.6 in the TAV group (p = 0.4). The correlation was linear and comparable between the maximum indexed aortic diameter and the angle between the left ventricular outflow axis and aortic root (left ventricle/aorta angle) in both groups (BAV group: r = 0.6, p < 0.001 vs. TAV group r = 0.45, p = 0.03, z = 1.26, p = 0.2). Logistic regression identified the left ventricle/aorta angle as an indicator of indexed aortic diameter >22 mm/m(2) (odds ratio: 1.2; p < 0.001).
CONCLUSIONS: Comparable correlation patterns between functional aortic root parameters and expression of aortopathy are found in patients with BAV versus TAV stenosis.
Copyright © 2016 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  aorta; bicuspid aortic valve; hemodynamics; valves

Mesh:

Year:  2016        PMID: 27081018     DOI: 10.1016/j.jacc.2016.02.015

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  14 in total

1.  Aortic stenosis exacerbates flow aberrations related to the bicuspid aortic valve fusion pattern and the aortopathy phenotype.

Authors:  Yan Shan; Jun Li; Yongshi Wang; Boting Wu; Alex J Barker; Michael Markl; Chunsheng Wang; Xiaolin Wang; Xianhong Shu
Journal:  Eur J Cardiothorac Surg       Date:  2019-03-01       Impact factor: 4.191

Review 2.  Bicuspid aortic valve and aortic coarctation in congenital heart disease-important aspects for treatment with focus on aortic vasculopathy.

Authors:  Christoph Sinning; Elvin Zengin; Rainer Kozlik-Feldmann; Stefan Blankenberg; Carsten Rickers; Yskert von Kodolitsch; Evaldas Girdauskas
Journal:  Cardiovasc Diagn Ther       Date:  2018-12

Review 3.  Aortic valvular imaging with cardiovascular magnetic resonance: seeking for comprehensiveness.

Authors:  Gianluca De Rubeis; Nicola Galea; Isabella Ceravolo; Gian Marco Dacquino; Iacopo Carbone; Carlo Catalano; Marco Francone
Journal:  Br J Radiol       Date:  2019-07-18       Impact factor: 3.039

4.  Association between flow skewness and aortic dilatation in patients with aortic stenosis.

Authors:  Hojin Ha; Hyun Jung Koo; June Goo Lee; Guk Bae Kim; Jihoon Kweon; Sang Joon Lee; Joon Won Kang; Tae Hwan Lim; Dae Hee Kim; Jong Min Song; Duk Hyun Kang; Jae Kwan Song; Young Hak Kim; Namkug Kim; Dong Hyun Yang
Journal:  Int J Cardiovasc Imaging       Date:  2017-06-16       Impact factor: 2.357

5.  Effect of Aortic Valve Disease on 3D Hemodynamics in Patients With Aortic Dilation and Trileaflet Aortic Valve Morphology.

Authors:  Kenichiro Suwa; Ozair Abdul Rahman; Emilie Bollache; Michael J Rose; Amir Ali Rahsepar; James C Carr; Jeremy D Collins; Alex J Barker; Michael Markl
Journal:  J Magn Reson Imaging       Date:  2019-06-06       Impact factor: 4.813

6.  Valve mediated hemodynamics and their association with distal ascending aortic diameter in bicuspid aortic valve subjects.

Authors:  Vrishank Raghav; Alex J Barker; Daniel Mangiameli; Lucia Mirabella; Michael Markl; Ajit P Yoganathan
Journal:  J Magn Reson Imaging       Date:  2017-04-08       Impact factor: 4.813

Review 7.  Bicuspid aortic valve related aortopathy.

Authors:  Sina Stock; Salah A Mohamed; Hans-Hinrich Sievers
Journal:  Gen Thorac Cardiovasc Surg       Date:  2017-08-30

8.  The American Association for Thoracic Surgery consensus guidelines on bicuspid aortic valve-related aortopathy: Full online-only version.

Authors:  Michael A Borger; Paul W M Fedak; Elizabeth H Stephens; Thomas G Gleason; Evaldas Girdauskas; John S Ikonomidis; Ali Khoynezhad; Samuel C Siu; Subodh Verma; Michael D Hope; Duke E Cameron; Donald F Hammer; Joseph S Coselli; Marc R Moon; Thoralf M Sundt; Alex J Barker; Michael Markl; Alessandro Della Corte; Hector I Michelena; John A Elefteriades
Journal:  J Thorac Cardiovasc Surg       Date:  2018-08       Impact factor: 5.209

9.  Therapeutic approach comparison in bicuspid aortic valve aortopathy and clinical practice implications.

Authors:  Ciprian Nicuşor Dima; Caius Glad Streian; Marian Gaşpar; Silviu Cristian Suciu; Constantin Caraion; Elian Octavian Boldu; Simona Cerbu; Emil Radu Iacob; Constantin Tudor Luca; Lucian Petrescu
Journal:  Rom J Morphol Embryol       Date:  2020 Jul-Sep       Impact factor: 1.033

10.  The influence of the aortic valve angle on the hemodynamic features of the thoracic aorta.

Authors:  Hojin Ha; Guk Bae Kim; Jihoon Kweon; Sang Joon Lee; Young-Hak Kim; Namkug Kim; Dong Hyun Yang
Journal:  Sci Rep       Date:  2016-08-26       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.